Cardiff Lexington Corp.
- CDIX ยท OTC
- Services-Offices & Clinics of Doctors of Medicine
- Lexington, KY
- 18 employees
- CIK 0000811222
Updated from SEC filings through
Top things to know
Executives
-
Alex H. Cunningham Chief Executive Officer 4, 2026-02-02 - Matthew T. Shafer Chief Financial Officer 4, 2026-01-16
- Daniel Thompson Chairman of the Board 4, 2025-12-15
Cardiff Lexington Corp is a U.S. public company in services-offices & clinics of doctors of medicine (SIC 8011), headquartered in Lexington, KY. It trades as CDIX on OTC. Revenue was $11.5M in the fiscal year ending December 31, 2025, +39.5% from the year before. It reported about 18 employees. Alex H. Cunningham is Chief Executive Officer.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $11.5M 10-K, 2026-03-10 | $8.3M 10-K, 2026-03-10 | $11.9M 10-K, 2025-08-19 | $10.7M 10-K/A, 2024-08-08 | $9.9M 10-K, 2023-06-06 |
| Operating income | $1.1M 10-K, 2026-03-10 | -$194K 10-K, 2026-03-10 | $5.2M 10-K, 2025-08-19 | $3.9M 10-K/A, 2024-08-08 | $1.7M 10-K, 2023-06-06 |
| SG&A | $5.3M 10-K, 2026-03-10 | $4.1M 10-K, 2026-03-10 | $3.1M 10-K, 2025-08-19 | $2.7M 10-K/A, 2024-08-08 | $4.4M 10-K, 2023-06-06 |
| Net income | -$5.5M 10-K, 2026-03-10 | -$3.3M 10-K, 2026-03-10 | $3.0M 10-K, 2025-08-19 | -$5.4M 10-K/A, 2024-08-08 | $666K 10-K, 2023-06-06 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Alex H. Cunningham MBA ~Healthcare Acquisitions~ Expansion Capitalization~ Entrepreneur Equity Exit Strategies~Risk Mitigation | Chief Executive Officer | 4, 2026-02-02 |
| Matthew T. Shafer | Chief Financial Officer | 4, 2026-01-16 |
| Daniel Thompson | Chairman of the Board | 4, 2025-12-15 |
What Cardiff Lexington Corp does
Our company is a targeted healthcare holding company dedicated to acquiring and building middle-market niche healthcare clinics, primarily in orthopedics, spine care, and pain management.
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Shares outstanding | 15.6 million (as of August 10, 2026) | 10-Q, August 12, 2026 |
|---|---|---|
| Public float | $45.4M (as of June 30, 2025) | 10-K, March 10, 2026 |
| Reportable segments | 2 (period ending June 30, 2026) | 10-Q, August 12, 2026 |
| Latest proxy statement | Meeting March 26, 2015 (filed February 27, 2015) | DEF 14A, February 27, 2015 |
| Auditor | GBQ Partners, LLC (Columbus, Ohio) | Latest 10-K |
Recent 8-K events
- 8-K filed 2026-09-24
- Item 8.01 Other events
- 8-K filed 2026-09-04
- Item 3.03 Material modification to rights of security holders
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- 8-K filed 2026-06-11
- Item 1.01 Entry into a material definitive agreement
- 8-K filed 2026-02-03
- Item 3.03 Material modification to rights of security holders
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- 8-K filed 2026-01-05
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2025-08-14
- Item 4.02 Non-reliance on previously issued financial statements
- 8-K filed 2024-12-04
- Item 3.03 Material modification to rights of security holders
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- 8-K filed 2024-10-17
- Item 4.02 Non-reliance on previously issued financial statements
- 8-K filed 2024-09-19
- Item 4.01 Changes in registrant's certifying accountant
- 8-K filed 2024-06-11
- Item 1.01 Entry into a material definitive agreement
Frequently asked questions about Cardiff Lexington Corp
- What does Cardiff Lexington Corp do?
- In its own words, from Item 1 of its 10-K: "Our company is a targeted healthcare holding company dedicated to acquiring and building middle-market niche healthcare clinics, primarily in orthopedics, spine care, and pain management."
- What is Cardiff Lexington Corp's revenue?
- $11.5M for the fiscal year ending December 31, 2025, from its 10-K filed March 10, 2026.
- Is Cardiff Lexington Corp profitable?
- Cardiff Lexington Corp reported net income of -$5.5M for the fiscal year ending December 31, 2025.
- How many employees does Cardiff Lexington Corp have?
- About 18 as of December 31, 2025, as stated in its annual report.
- Who is the CEO of Cardiff Lexington Corp?
- Alex H. Cunningham, Chief Executive Officer, as named in a 4 filed February 2, 2026.
- Who is the CFO of Cardiff Lexington Corp?
- Matthew T. Shafer, Chief Financial Officer, as named in a 4 filed January 16, 2026.
- Where is Cardiff Lexington Corp headquartered?
- Lexington, KY.
- What is Cardiff Lexington Corp's stock ticker?
- CDIX on OTC.
- What industry is Cardiff Lexington Corp in?
- Services-Offices & Clinics of Doctors of Medicine, SIC code 8011.
- What is Cardiff Lexington Corp's website?
- cardifflexington.com. Investor relations: https://cardifflexington.com/investors/.
- When does Cardiff Lexington Corp report earnings next?
- November 12, 2026. Source: estimate_10q_cadence.
- Is Cardiff Lexington Corp a public company?
- Yes. Cardiff Lexington Corp files with the SEC under CIK 0000811222 and trades as CDIX.
- Who audits Cardiff Lexington Corp?
- GBQ Partners, LLC, Columbus, Ohio, as named in its latest annual report (10-K).
- How many shares of Cardiff Lexington Corp are outstanding?
- 15.6 million shares as of August 10, 2026, from its 10-Q filed August 12, 2026.
- What is Cardiff Lexington Corp's public float?
- $45.4M as of June 30, 2025, as reported on the cover of its 10-K filed March 10, 2026.
- How many business segments does Cardiff Lexington Corp report?
- 2 reportable segments for the period ending June 30, 2026, from its 10-Q filed August 12, 2026.
- When is Cardiff Lexington Corp's annual shareholder meeting?
- March 26, 2015, per its proxy statement (DEF 14A) filed February 27, 2015.